Predictive Technology Group, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRED research report →
Companywww.predtechgroup.com
Predictive Technology Group, Inc. , together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics.
- CEO
- Bradley C. Robinson
- IPO
- 2008
- Employees
- 62
- HQ
- Salt Lake City, UT, US
Price Chart
Valuation
- Market Cap
- $89.88K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.09
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 15.78%
- Op Margin
- -190.92%
- Net Margin
- -351.44%
- ROE
- -155.36%
- ROIC
- -63.59%
Growth & Income
- Revenue
- $24.44M · -43.80%
- Net Income
- $-85,897,009 · -456.89%
- EPS
- $-0.30 · -416.35%
- Op Income
- $-46,663,175
- FCF YoY
- -1892.34%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.77
- Avg Volume
- 0
Get TickerSpark's AI analysis on PRED
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PRED Coverage
We haven't published any research on PRED yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PRED Report →